beauk의 경제 이야기

Halozyme Therapeutics: A Drug Delivery Innovator Reshaping Biopharma Pioneering Subcutaneous Drug Delivery with ENHANZE®Halozyme’s defining innovation lies in its ENHANZE® platform, based on the recombinant human enzyme rHuPH20. This technology enables the transformation of IV biologics into subcutaneous injections, offering shorter administration times and greater patient comfort. ENHANZE® is w..

U.S. Financial Market Update – May 12 2025 U.S.–China Tariff Truce: Markets Soar Amid 90-Day Agreement Key Agreement on Tariff ReductionsThe U.S. and China have agreed to significantly scale back mutual tariffs for a 90-day period. Washington will cut its tariffs on Chinese imports from a staggering 145% to 30%, while Beijing will reduce its tariffs on U.S. goods to 10%. This marks a major de-e..